{"record_type":"pith_number_record","schema_url":"https://pith.science/schemas/pith-number/v1.json","pith_number":"pith:2026:FAIZ7R4GA6RRBPI4P2C7LTDMLW","short_pith_number":"pith:FAIZ7R4G","schema_version":"1.0","canonical_sha256":"28119fc78607a310bd1c7e85f5cc6c5da6389bd1007f0f52560d8f1fe60700be","source":{"kind":"arxiv","id":"2605.17240","version":1},"attestation_state":"computed","paper":{"title":"The FORSS Framework for Sample Size and Power Calculations With Win Statistics for Hierarchical Endpoints","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"The FORSS framework delivers accurate formula-based sample size and power calculations for win statistics on hierarchical endpoints.","cross_cats":[],"primary_cat":"stat.ME","authors_text":"Baoshan Zhang, Huiman X. Barnhart, Roland A. Matsouaka, Yuan Wu","submitted_at":"2026-05-17T03:44:41Z","abstract_excerpt":"Win statistics have gained increasing popularity as primary analysis methods for clinical trials with hierarchical endpoints (HEs) as primary endpoints. However, existing sample size and power calculation approaches in trial design still face several limitations and challenges: simulation-based approaches are computationally intensive, while existing formula-based methods often rely on simplifying assumptions such as independence among HEs, or require specification of overall win statistics and tie probability that are difficult to elicit a priori in practice. To address these challenges, we p"},"verification_status":{"content_addressed":true,"pith_receipt":true,"author_attested":false,"weak_author_claims":0,"strong_author_claims":0,"externally_anchored":false,"storage_verified":false,"citation_signatures":0,"replication_records":0,"graph_snapshot":true,"references_resolved":true,"formal_links_present":true},"canonical_record":{"source":{"id":"2605.17240","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2026-05-17T03:44:41Z","cross_cats_sorted":[],"title_canon_sha256":"f435e956955e3b7fed439e415d43f0713416806b3555986f59b370390b5ac291","abstract_canon_sha256":"cf93b544b38957a6ab00cf4263a5a31c29404299f15e7c2de400a083fa9b4fee"},"schema_version":"1.0"},"receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-20T00:03:47.031233Z","signature_b64":"lHsJ8q2+pFdxZi1M7Dy3GxbnbZZD9CcPkOak8o7nTWu3ALznNkmueL/wgJZiJRqcTsag32GLHQ+R6JcyKlSEDw==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"28119fc78607a310bd1c7e85f5cc6c5da6389bd1007f0f52560d8f1fe60700be","last_reissued_at":"2026-05-20T00:03:47.030345Z","signature_status":"signed_v1","first_computed_at":"2026-05-20T00:03:47.030345Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"graph_snapshot":{"paper":{"title":"The FORSS Framework for Sample Size and Power Calculations With Win Statistics for Hierarchical Endpoints","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"The FORSS framework delivers accurate formula-based sample size and power calculations for win statistics on hierarchical endpoints.","cross_cats":[],"primary_cat":"stat.ME","authors_text":"Baoshan Zhang, Huiman X. Barnhart, Roland A. Matsouaka, Yuan Wu","submitted_at":"2026-05-17T03:44:41Z","abstract_excerpt":"Win statistics have gained increasing popularity as primary analysis methods for clinical trials with hierarchical endpoints (HEs) as primary endpoints. However, existing sample size and power calculation approaches in trial design still face several limitations and challenges: simulation-based approaches are computationally intensive, while existing formula-based methods often rely on simplifying assumptions such as independence among HEs, or require specification of overall win statistics and tie probability that are difficult to elicit a priori in practice. To address these challenges, we p"},"claims":{"count":4,"items":[{"kind":"strongest_claim","text":"The formula-based FORSS closely matches empirical power across a wide range of scenarios while maintaining Type I error rates near the nominal 5% level.","source":"verdict.strongest_claim","status":"machine_extracted","claim_id":"C1","attestation":"unclaimed"},{"kind":"weakest_assumption","text":"That a user-specified flexible joint working distribution for the hierarchical endpoints, together with marginal treatment effects, is sufficient to generate super-samples whose plug-in estimates accurately support the analytical power and sample-size formulas.","source":"verdict.weakest_assumption","status":"machine_extracted","claim_id":"C2","attestation":"unclaimed"},{"kind":"one_line_summary","text":"FORSS is a new formula-based super-sample framework for power and sample size calculations with win statistics on hierarchical endpoints that incorporates marginal effects and a flexible joint distribution.","source":"verdict.one_line_summary","status":"machine_extracted","claim_id":"C3","attestation":"unclaimed"},{"kind":"headline","text":"The FORSS framework delivers accurate formula-based sample size and power calculations for win statistics on hierarchical endpoints.","source":"verdict.pith_extraction.headline","status":"machine_extracted","claim_id":"C4","attestation":"unclaimed"}],"snapshot_sha256":"dc16caac42f37b5ea39491e2b5169aa529976a5478c455a6ca9edaac97f59f6d"},"source":{"id":"2605.17240","kind":"arxiv","version":1},"verdict":{"id":"ccf5cced-ab53-4bd9-aa93-273890545801","model_set":{"reader":"grok-4.3"},"created_at":"2026-05-19T23:32:08.511665Z","strongest_claim":"The formula-based FORSS closely matches empirical power across a wide range of scenarios while maintaining Type I error rates near the nominal 5% level.","one_line_summary":"FORSS is a new formula-based super-sample framework for power and sample size calculations with win statistics on hierarchical endpoints that incorporates marginal effects and a flexible joint distribution.","pipeline_version":"pith-pipeline@v0.9.0","weakest_assumption":"That a user-specified flexible joint working distribution for the hierarchical endpoints, together with marginal treatment effects, is sufficient to generate super-samples whose plug-in estimates accurately support the analytical power and sample-size formulas.","pith_extraction_headline":"The FORSS framework delivers accurate formula-based sample size and power calculations for win statistics on hierarchical endpoints."},"integrity":{"clean":false,"summary":{"advisory":1,"critical":0,"by_detector":{"doi_compliance":{"total":1,"advisory":1,"critical":0,"informational":0}},"informational":0},"endpoint":"/pith/2605.17240/integrity.json","findings":[{"note":"DOI in the printed bibliography is fragmented by whitespace or line breaks. A longer candidate (10.1161/CIRC-HEARTFAILURE.120.008100) was visible in the surrounding text but could not be confirmed against doi.org as printed.","detector":"doi_compliance","severity":"advisory","ref_index":16,"audited_at":"2026-05-19T23:41:43.526904Z","detected_doi":"10.1161/CIRC-HEARTFAILURE.120.008100","finding_type":"recoverable_identifier","verdict_class":"incontrovertible","detected_arxiv_id":null}],"available":true,"detectors_run":[{"name":"doi_title_agreement","ran_at":"2026-05-20T00:01:20.673021Z","status":"completed","version":"1.0.0","findings_count":0},{"name":"doi_compliance","ran_at":"2026-05-19T23:41:43.526904Z","status":"completed","version":"1.0.0","findings_count":1},{"name":"claim_evidence","ran_at":"2026-05-19T22:01:57.883525Z","status":"completed","version":"1.0.0","findings_count":0},{"name":"ai_meta_artifact","ran_at":"2026-05-19T21:33:23.796777Z","status":"skipped","version":"1.0.0","findings_count":0}],"snapshot_sha256":"94cb443ce66cd8e545e79cc211ad7a7a273850e5354d88084b2ef890fce6f4b6"},"references":{"count":39,"sample":[{"doi":"10.1136/bmj.330.7491.594","year":2005,"title":"Validity of composite end points in clinical trials.BMJ 2005; 330(7491): 594–596","work_id":"9b907427-4b76-4217-ae41-62883404f61c","ref_index":1,"cited_arxiv_id":"","is_internal_anchor":false},{"doi":"","year":null,"title":"WalkerHG,BrownAJ,VazIP,etal.Compositeoutcomemeasuresinhigh-impactcriticalcarerandomisedcontrolledtrials: a systematic review.Critical Care2024; 28(1): 184","work_id":"f150c214-956d-4840-809f-08ab13385f5d","ref_index":2,"cited_arxiv_id":"","is_internal_anchor":false},{"doi":"10.1016/j.cardfail.2005.08.350","year":2005,"title":"Key Issues in End Point Selection for Heart Failure Trials: Composite End Points.Journal of Cardiac Failure2005; 11(8): 567–575","work_id":"ef27510a-e057-49c1-9387-89a013554ac0","ref_index":3,"cited_arxiv_id":"","is_internal_anchor":false},{"doi":"","year":null,"title":"Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials.Bmj2007; 334(7597): 786","work_id":"0f2f9028-9273-49f0-967c-79b5a26319eb","ref_index":4,"cited_arxiv_id":"","is_internal_anchor":false},{"doi":"10.1002/(sici)1097-0258(19990615)18:11","year":null,"title":"doi: 10.1002/(SICI)1097-0258(19990615)18:11<1341::AID-SIM129>3.0.CO;2-7","work_id":"5641e84d-6c8c-4219-9f71-c2e744cb0b68","ref_index":5,"cited_arxiv_id":"","is_internal_anchor":false}],"resolved_work":39,"snapshot_sha256":"3e9d4deb600e14697f2525904b2de22361dbb741e3cc0798cbd89b211022fae8","internal_anchors":0},"formal_canon":{"evidence_count":2,"snapshot_sha256":"e4556ab2a6d16f399b240fdc9e3bf7d2872c191ee4093eb5fab035e8141c0912"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"aliases":[{"alias_kind":"arxiv","alias_value":"2605.17240","created_at":"2026-05-20T00:03:47.030494+00:00"},{"alias_kind":"arxiv_version","alias_value":"2605.17240v1","created_at":"2026-05-20T00:03:47.030494+00:00"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2605.17240","created_at":"2026-05-20T00:03:47.030494+00:00"},{"alias_kind":"pith_short_12","alias_value":"FAIZ7R4GA6RR","created_at":"2026-05-20T00:03:47.030494+00:00"},{"alias_kind":"pith_short_16","alias_value":"FAIZ7R4GA6RRBPI4","created_at":"2026-05-20T00:03:47.030494+00:00"},{"alias_kind":"pith_short_8","alias_value":"FAIZ7R4G","created_at":"2026-05-20T00:03:47.030494+00:00"}],"events":[],"event_summary":{},"paper_claims":[],"inbound_citations":{"count":0,"internal_anchor_count":0,"sample":[]},"formal_canon":{"evidence_count":2,"sample":[],"anchors":[]},"links":{"html":"https://pith.science/pith/FAIZ7R4GA6RRBPI4P2C7LTDMLW","json":"https://pith.science/pith/FAIZ7R4GA6RRBPI4P2C7LTDMLW.json","graph_json":"https://pith.science/api/pith-number/FAIZ7R4GA6RRBPI4P2C7LTDMLW/graph.json","events_json":"https://pith.science/api/pith-number/FAIZ7R4GA6RRBPI4P2C7LTDMLW/events.json","paper":"https://pith.science/paper/FAIZ7R4G"},"agent_actions":{"view_html":"https://pith.science/pith/FAIZ7R4GA6RRBPI4P2C7LTDMLW","download_json":"https://pith.science/pith/FAIZ7R4GA6RRBPI4P2C7LTDMLW.json","view_paper":"https://pith.science/paper/FAIZ7R4G","resolve_alias":"https://pith.science/api/pith-number/resolve?arxiv=2605.17240&json=true","fetch_graph":"https://pith.science/api/pith-number/FAIZ7R4GA6RRBPI4P2C7LTDMLW/graph.json","fetch_events":"https://pith.science/api/pith-number/FAIZ7R4GA6RRBPI4P2C7LTDMLW/events.json","actions":{"anchor_timestamp":"https://pith.science/pith/FAIZ7R4GA6RRBPI4P2C7LTDMLW/action/timestamp_anchor","attest_storage":"https://pith.science/pith/FAIZ7R4GA6RRBPI4P2C7LTDMLW/action/storage_attestation","attest_author":"https://pith.science/pith/FAIZ7R4GA6RRBPI4P2C7LTDMLW/action/author_attestation","sign_citation":"https://pith.science/pith/FAIZ7R4GA6RRBPI4P2C7LTDMLW/action/citation_signature","submit_replication":"https://pith.science/pith/FAIZ7R4GA6RRBPI4P2C7LTDMLW/action/replication_record"}},"created_at":"2026-05-20T00:03:47.030494+00:00","updated_at":"2026-05-20T00:03:47.030494+00:00"}